Treatment of relapsing polychondritis with tocilizumab

Journal of Rheumatology

Volumn 40, Issue 7, 2013, Pages 1232-

  Wendling, Daniel ^a   Godfrin Valnet, Marie ^a   Prati, Clement ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DAPSONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB;

ADULT; CASE REPORT; CHONDRITIS; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RELAPSE; RELAPSING POLYCHONDRITIS; REMISSION; SYNOVITIS; TENOSYNOVITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; POLYCHONDRITIS, RELAPSING; RECEPTORS, INTERLEUKIN-6;

EID: 84879985398     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130371     Document Type: Letter

References (5)

1. Wallace ZS, Stone JH. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade [letter]. J Rheumatol 2013;40:100-2.
2. Wendling D, Govindaraju S, Prati C, Toussirot E, Bertolini E. Efficacy of anakinra in a patient with refractory relapsing polychondritis. Joint Bone Spine 2008;75:622-4.
3. Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, et al. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Rheumatology 2009;48:318-9.
4. Narshi CB, Allard SA. Sustained response to tocilizumab, anti IL-6 antibody, following anti TNF-〈 failure in a patient with relapsing polychondritis complicated by aortitis. Rheumatology 2012;51:952-3.
5. Kemta Lekpa F, Kraus VB, Chevalier X. Biologics in relapsing polychondritis: A literature review. Semin Arthritis Rheum 2012;41:712-9.